Sage depression drug to cost between $20K and $35K, if approved

Sage depression drug to cost between $20K and $35K, if approved

Source: 
Biopharma Dive
snippet: 

Sage Therapeutics plans to price its postpartum depression drug Zulresso between $20,000 and $35,000 per course of treatment, if the Food and Drug Administration approves the therapy as expected in December.